2020
DOI: 10.3390/molecules25061259
|View full text |Cite
|
Sign up to set email alerts
|

Mycobacterium tuberculosis Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs

Abstract: Roughly a third of the world’s population is estimated to have latent Mycobacterium tuberculosis infection, being at risk of developing active tuberculosis (TB) during their lifetime. Given the inefficacy of prophylactic measures and the increase of drug-resistant M. tuberculosis strains, there is a clear and urgent need for the development of new and more efficient chemotherapeutic agents, with selective toxicity, to be implemented on patient treatment. The component enzymes of the shikimate pathway, which is… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
15
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 44 publications
(21 citation statements)
references
References 165 publications
0
15
0
Order By: Relevance
“…The shikimate pathway is considered an attractive target for developing new rational-based antimicrobial agents ( 11 ). It is essential for bacterial growth but absent in most animals, including mammals, favoring the development of selective inhibitors for pathogenic bacteria ( 12 , 13 ).…”
Section: Introductionmentioning
confidence: 99%
“…The shikimate pathway is considered an attractive target for developing new rational-based antimicrobial agents ( 11 ). It is essential for bacterial growth but absent in most animals, including mammals, favoring the development of selective inhibitors for pathogenic bacteria ( 12 , 13 ).…”
Section: Introductionmentioning
confidence: 99%
“…A model allosteric protein for evaluating these factors is Saccharomyces cerevisiae chorismate mutase (ScCM). CM enzymes are important regulatory enzymes in the shikimate pathway, which is responsible for the production of the amino acids Phe, Tyr, and Trp as well as other aromatic compounds such as ubiquinone and folate. , There is interest in developing shikimate pathway inhibitors as novel antimicrobials as well as engineering this pathway to help in the production of food flavorings, preservatives, and other compounds . Chorismate mutases catalyze the pericyclic [3,3]-sigmatropic rearrangement of chorismate to prephenate by stabilizing the chair conformation of chorismate, which resembles the transition state (Figure S1).…”
mentioning
confidence: 99%
“…Biosynthesis of flavonols from p-coumaroyl-CoA and malonyl-CoA. Enzymatic reaction catalyzed by DAHPS: 3-deoxy-D-arabino-heptulosonate-7-phosphate-synthase; DHQS: 3-dexydroquinate synthase; SDO: shikimate dehydrogenase; PAL: phenylalanine ammonia-lyase; TAL: tyrosine ammonia lyase; C4H: cinnamate 4-hydroxylase; CHI: chalcone isomerase, FHT: flavanone 3β-hydroxylase; FNS Ι: flavone synthase Ι; FLS: flavonol synthase; FMO: flavonoid 3′-monooxygenase; CPR: cytochrome P450reductase [ 8 , 9 , 10 ].…”
Section: Figurementioning
confidence: 99%